https://mmitnetwork.com

Pharmaceutical, Healthcare and Payer Business Solutions | MMITMMIT is a trusted, go-to-market partner that provides a platform, insights, and consulting services to move lifesaving therapies from pipeline to patients.Pharmaceutical, Healthcare and Payer Business Solutions | MMIT Careers LOGIN Search for:Search Button SUBSCRIBE TODAY Our Solutions Payer Data Intelligence Solutions Analytics Contract Validation Lab Data for Commercial Targeting Bridging as a Service API Payer Landscape Directory of Health Plans Strategic Launch Report Surveillance Launch Coverage Analytics MMIT Reach Payer & Provider Insights Solutions PULSE Analytics Patient Access Analytics P&T Perspectives Biologics & Injectables Index Oncology Index Formulary Insights Message Monitor Engage Rapid Response Consulting Services Payer Solutions Pricing Submission Program Navigator Medical Drug Lists ReimbursementCodes RC Claim Assist Fee Scheduler Promotional Solutions FormTrak Coverage Search Communication Program Specialty Pharmacy Solutions Patient Reimbursement Database Patient and Office Staff Satisfaction Surveys How We Help Thought Leadership Thought Leadership Blog Spotlight on Market Access Specialty Drug Reimbursement Newsletter State of Patient Access Webinar AIS HEALTH Health Plan Weekly Radar on Medicare Advantage Radar on Drug Benefits Radar on Specialty Pharmacy Resources Who We Are Careers Join Our Panel Life at MMIT News & Events MMIT Patient Access Awards Meet Our Team CONTACT US Support Payer Data Intelligence Solutions Analytics Contract Validation Lab Data for Commercial Targeting Bridging as a Service Payer Landscape Directory of Health Plans Strategic Launch Report Surveillance Launch Coverage Analytics MMIT Reach Payer and Provider Insights Solutions PULSE Analytics Patient Access Analytics P&T Perspectives Biologics & Injectables Index Oncology Index Formulary Insights Message Monitor API Custom Market Research Engage Rapid Response Consulting Services Payer Solutions Pricing Submission Program Navigator Medical Drug Lists ReimbursementCodes RC Claim Assist Fee Scheduler Promotional Solutions FormTrak Coverage Search Communication Program Specialty Pharmacy Solutions Patient Reimbursement Database Patient and Office Staff Satisfaction Surveys SUBSCRIBE TODAY Market Access Build strategies for pre- and post-drug launch Effectively communicate with payers at Drug launch Gain a deeper understanding of payer market Understand payer and provider behavior Monitor competitors' messaging and strategy Patient Journey Understand how a patient gets on or off therapy Help patients overcome barriers to treatment Use lab data to target the right physicians and Patient Populations Brand Performance and Strategy Develop effective messaging and targeting for HCPs Develop and convey your brand value prop to decision-makers Deploy Field Reps Based on HCP and Payer Behavior Contracting and Reimbursement Simplify pricing and coding Effectively manage and share formulary changes Evaluate specialty pharmacy performance Validate formulary and medical benefit contracts BlockDEMOPAYER, PROVIDERS AND PHARMACIESHEALTHCAREPHARMAWe Answer the “What” and the “Why” ofMarket Access. LET'S TALKSolutions for Pharmaceutical ManufacturersOur customers rely on our industry-leading data and insights and cutting-edge technology to overcome barriers to access.LEARN MORESolutions for Healthcare ITLet our unbeatable covered lives methodology and innovative technology inform your market access strategy.LEARN MORESolutions for Payers, Providers and PharmaciesEstablish reimbursement policies, formulary positioning and access financial assistance that make therapies affordable for patients.LEARN MOREDirectory of Health PlansYour source of truth for payer market share. Try out the Directory of Health Plans demo today.ACCESS THE DEMO Slide 1InsightsThe 2024 State of Patient AccessMMIT interviewed more than 300 pharma and biotech leaders to learn what keeps them up at night—and what gets them going in the morning. Read on for the survey findings and expert analysis. LEARN MORESlide 1InsightsUnleash the Power of Real-World DataMMIT helps pharma companies harness the power of real world data to better understand the patient journey. LEARN MORESlide 1HCP Targeting ReportFind High-Value HCPs for Your TherapyOne of the first steps in your therapy’s commercialization journey should be to identify high-value HCPs who can help guide valuation, messaging and more. LEARN MORESlide 1InsightsIntelligent InsightsOur Zitter Insights Panel uses research to illuminate the complexities of market access. LEARN MORE BlockMeet the expertPre-Launch Market Access PreparationWebinar available on September 17, 2024 |1:00pm EDT Market access is a critical function of a drug’s go-to-market strategy, as it sets the stage for a successful debut. In the months before launch, your market access team must lay the groundwork for your drug’s pricing, contracting, reimbursement and fulfillment strategies. REGISTER TODAY06Days23Hours53Minutes27Seconds Slide 1Industry Leading Insights MMIT offers a range of publications for pharma, payers and providers covering news, strategy and insights across the spectrum. Our in-house journalism division AIS Health provides objective news and analysis of industry trends while RJ Health provides a comprehensive look at industry updates as they apply to medically covered drug reimbursement processes. Slide 5"We need doctors to fight the good fight so that any patient who needs the therapy can get the therapy, and MMIT plays a key role in that process. We need you to help us fulfill our mission for our patients."Vice President of Market AccessSmall Pharma CompanySlide 2"As a small company, we appreciate the flexibility and responsiveness of the MMIT team. Their customer support team has done a great job working with our new hires to get them trained on their solutions."Mark DevlinVice President, Head of Market Access | Phathom PharmaceuticalsSlide 1“Ryan [Witherington] and the team at MMIT have been great partners in our initiatives to analyze and communicate payer policy data for our product through innovative field tools, both MMIT-developed and developed by us using MMIT data. FormTrak Web, in particular, has been well-received by our field sales team and we are excited to transition to FormTrak in Veeva to streamline the process and make it an even more valuable tool.”Director of Market AccessLarge Pharma CompanySlide 3“DHP provided us a list that was stronger than what we typically begin with, which, in turn, lowered the amount of time spent on payer that didn’t fit our profile.”Erin StudstillVice President of Operations and Technology | MarketLauncherSlide 4"Throughout my 10 years in market access, I've been exposed to most of the top solutions, at times simultaneously. I've always found myself turning to MMIT because of their products' ease of use and data integrity."Jai PersicoNational Account Executive | Neurocrine Biosciences TL 1Thought LeadershipKey Benefits of Early Market Access PlanningAccording to our 2024 State of Patient Access survey, 81% of pharma companies are launching their market access planning much earlier than they did five years ago. READ MORETL 2Thought LeadershipTremendous Growth in 2024 Health Insurance Exchange MembershipFor the past year, Medicaid has been the predominant topic of conversation for those who monitor insurance market share shifts READ MORETL 3Thought LeadershipWhen Payers Become Producers: Inside the Private-Labeling TrendVertical integration between payers, PBMs, specialty pharmacies, and providers has grown in the last decade, with more negotiating power concentrated among a handful of major players. READ MORETL 4Thought LeadershipCoding Chaos: How Pharma Can Help Providers Get PaidFor manufacturers of medical benefit drugs, ensuring accurate provider reimbursement is essential. If providers are unaware of how to appropriately bill for a particular drug, their errors will result in claims denials, which in turn may lead them to stop prescribing that drug in favor of another. READ MORETL 5Thought LeadershipWhy Pharma Should Invest in Evidence-Based Physician EducationFor years, many manufacturers have assumed that pre-market physician education was not strictly necessary unless their brand was the first to market or had a novel mechanism of action. READ MORETL 6Thought LeadershipPreparing for the Inflation Reduction Act’s Impact on Medicare PlansSince its passage in 2022, many have speculated on the impact of the Inflation Reduction Act (IRA) on providers, manufacturers and payers—especially those with Medicare Advantage plans. READ MORE Subscribe to MMIT's Thought Leadership Get the latest from MMIT’s leading subject matter experts, receiving the latest posts right to your inbox. Top-quality thought leadership 100% free. subscribe today News and Media Specialty Pharmacy ContinuumSpecialty Pharmacy ContinuumWhat Keeps Pharmacy Stakeholders Up at Night?August 23, 2024 At Asembia's AXS24 Summit, MMIT's Dinesh Kabaleeswaran and The Dedham Group's Jen Klarer presented on the results of the 2024 State of Patient Access survey. In this article, Specialty Pharmacy Continuum shares key points from their presentation. READ MOREFierce HealthcareFierce HealthcarePBMs Defend Business Practices — But Lawmakers Aren’t ConvincedJuly 23, 2024 The House Committee on Oversight and Accountability held a hearing on the business practices of the three largest PBMs. Fierce Healthcare tapped MMIT’s Andrew Rouff for commentary on the investigation into whether PBMs are responsible for inflating drug prices. READ MORELife Science LeaderLife Science LeaderPatient Access Challenges Are Changing Pharma Investment StrategiesJuly 9, 2024 Patient access issues across the value chain are prompting manufacturers to invest in early-stage market access planning using real-world data. MMIT's Dinesh Kabaleeswaran and The Dedham Group's Jen Klarer explain these industry shifts. READ MOREM&MMM&MMPatient Access Challenges Are Changing Pharma Investment StrategiesJune 2, 2024 Eli Lilly's drug will be marketed under the brand name Kisunla for treating adults with early symptomatic Alzheimer’s disease. MM&M asked MMIT's Chief Clinical Officer Jayne Hornung for commentary on this exciting news. READ MOREPharma ExecutivePharmaceutical ExecutiveToday’s New Messaging Mix: The State of Pharma Marketing in 2024May 13, 2024 At a Pharmaceutical Executive roundtable event on the state of marketing in the pharmaceutical industry, MMIT's Jay Shah and Skipta's Glen Saunders shared their thoughts on digital strategies, the use of AI, and the impact of med-legal regulations on marketing campaigns. READ MOREISJR PaperInternational Journal of Science and Research Evaluating the Role of AI and Identifying Use-Cases in U.S. Managed Care OrganizationsApril 2024 This research paper explores how payers’ familiarity with AI tools and explores the likelihood of AI implementation to reduce administrative burden across managed care and government organizations. READ MOREPress ReleasePress ReleaseMMIT Announces Finalists of the Ninth Specialty Pharmacy Patient Choice AwardsMarch 20, 2024 Managed Markets Insight & Technology (MMIT), the trusted go-to-market partner for overcoming barriers to patient access, has announced the finalists of its ninth Specialty Pharmacy Patient Choice Awards. READ MOREDrug ChannelsDrug ChannelsCopay Accumulator and Maximizer Update: Adoption Expands as Legal Barriers GrowFebruary 14, 2024 This review of current benefit designs uses MMIT’s data on commercial plans’ use of copay accumulators and maximizers. READ MOREISJR PaperInternational Journal of Science and Research Evolving Site of Care Trends in the U.S. Managed Care EcosystemJanuary 20, 2024 The movement of care from high-cost, post-acute sites to lower-cost freestanding and non-acute sites has accelerated. This research paper explores the impact of payer site-of-care preferences across payers, oncologists and physicians. READ MOREPharma ExecutivePharmaceutical ExecutiveBuilding Awareness of Anti-Obesity Drugs: 2024 TrendsJanuary 18, 2024 The increased popularity of anti-obesity medications is raising questions about inequities in patient access, due to both shortages and limited payer coverage policies. READ MOREHealthcare IT TodayHealthcare IT TodayUses of AI in Healthcare: 2024 Health IT PredictionsJanuary 17, 2024 The application of AI will expand into managed care organizations in the near future. For payers and PBMs, AI tools can be useful for tasks including claims processing, prior authorization review, and data retrieval. READ MOREHealthcare IT TodayThe American Journal of Managed CareNavigating the Biosimilar Frontier: Opportunities and Challenges in 2024January 14, 2024 Biosimilars offer substantial promise for a new era of accessibility and affordability for patients, but better understanding of these products from payers and providers is necessary for biosimilars to reach their full potential. READ MOREPharmacy TimesPharmacy TimesClaims, Lab, And EHR Data Can Make Or Break A Drug LaunchJanuary 2, 2024 By blending claims, lab, and EHR data with payer coverage and clinical pathway data, pharma companies can gain full visibility into what’s happening in the market before they launch. READ MOREPress ReleasePress ReleaseMMIT Wins Titan Health Award for Healthcare InnovationDecember 4, 2023 Patient Access Analytics received the Gold Award for Technology Solutions in Healthcare. READ MOREin VivoIn VivoWorries And Hopes For Health Care Delivery In 2024November 29, 2023 Life sciences companies will face several challenges in the new year, from more pressure on pipelines to the ongoing consequences of regulatory changes. Norstella experts share their predictions. READ MOREBioPharma DiveBioPharma DiveUsing Real-World Data To Improve Patient Access To Oncology TherapiesOctober 9, 2023 Many oncology manufacturers assume that a therapy’s inclusion on clinical pathways is more important than its coverage profile, but this isn’t always true. READ MOREDrug ChannelsDrug ChannelsHow Payers Are Reacting To Insulin Price ChangesSeptember 15, 2023 Insulin price caps and list price reductions are a huge step forward for patient access. But what will these changes mean for health plans? READ MOREContract PharmaContract PharmaSolving Pharma’s Underlying Rebate Leakage ProblemSeptember 13, 2023 Rebate leakage drains millions in revenue from pharma companies every year. To ensure contract compliance, manufacturers can implement these five steps. READ MORE About Us MMIT, a Norstella company, believes that patients who need lifesaving treatments shouldn’t face delays because of the barriers to accessing therapies. As the leading provider of market access data, analytics and insights, our expert teams of pharmacists, clinicians, data specialists and market researchers provide clarity and confidence so that our clients can make better decisions. GENERAL EMAIL info@mmitnetwork.com LOCATION 1040 Stony Hill Rd #300, Yardley, PA 19067 PHONE (267) 753-6800 2024 Managed Markets Insight & Technology, LLC | info@mmitnetwork.com Privacy Policy Terms of Useenusen-US1726978849https://mmitnetwork.com

¿Sitio ukar chiqañchasma?

Kuns lurtä?